HomesToLife Prices Its IPO At $4/Share For 1.25M Shares By Investing.com

HomesToLife Prices Its IPO At $4/Share For 1.25M Shares By Investing.com
HomesToLife Prices Its IPO At $4/Share For 1.25M Shares By Investing.com

HomesToLife Ltd. (HTLM) today announced the pricing of its initial public offering of an aggregate of 1,250,000 shares of its common stock (the “Offering”), all offered by HTLM at a public offering price of $4.00 per action.

In addition, the Company has granted the underwriters a 45-day option (the “Over-Allotment Option”) to purchase up to 187,500 additional shares of common stock at the initial public offering price, less underwriting discounts and commissions. The gross proceeds to HTLM from the Offering (assuming that the Over-Allotment Option is not exercised), before deducting underwriting discounts and commissions and estimated offering expenses payable by HTLM, are expected to be $5 million $.

The shares are expected to begin trading on the Capital Market under the ticker symbol “HTLM” on 10/01/2024. The Offering is scheduled to close on 02/10/2024, subject to customary closing conditions.

US Tiger Securities, Inc. (“Tiger”) is the sole book-running manager for the Offering. Loeb & Loeb LLP is serving as U.S. legal advisor to the Company, and Hunter Taubman Fischer & Li LLC is serving as U.S. legal advisor to Tiger.

The Offering is being made pursuant to the Company’s registration statement on Form F-1 (File No. 333-281693) previously filed with and declared effective by the US Securities and Exchange Commission (“SEC”). here on 09/30/2024. The Offer is being made only by means of a prospectus. Before investing, you should read the prospectus and other documents the Company has filed or will file with the SEC for more information about the Company and the Offering. You can obtain these documents free of charge by visiting EDGAR on the SEC’s website at www.sec.gov. Alternatively, electronic copies of the prospectus relating to the Offering may be obtained from Tiger at 437 Madison Avenue, 27th Floor, New York, New York 10022, or by telephone at +1 646-978-5188.

This press release has been prepared for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

This article was generated and translated with the help of AI and reviewed by an editor. For more information, see our T&Cs.

-

-

PREV Gavin Creel, Tony Award winner and musical Broadway veteran, dies at 48
NEXT “This Bucks team is the closest to what I had in Boston in 2008”